Physician profile
Adam Harris
NPI 1114905478
$65,445.32
in general payments reported to CMS, 2019-2025
13 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $12.81 · 2021: $2,588 · 2022: $4,321 · 2023: $2,061 · 2024: $271 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,663 · Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,663.26 |
| Food and Beverage | $883.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $64,890.49 | 2019-2025 | Real Intelligence, Pico |
| Brixton Biosciences, INC. | $142.50 | 2024 | Neural Ice |
| Takeda Pharmaceuticals U.S.A., INC. | $89.51 | 2025 | Entyvio |
| Alafair Biosciences, INC. | $84.99 | 2024 | Versawrap |
| Vertex Pharmaceuticals Incorporated | $54.02 | 2025 | |
| Baxter Healthcare | $49.17 | 2023 | Floseal |
| Kci USA, INC. | $29.23 | 2019 | |
| Depuy Synthes Sales INC. | $28.12 | 2024 | Healix Knotless Peek, Truespan Orthocord |
| Convatec INC. | $27.61 | 2023 | |
| Fidia Pharma USA INC. | $16.30 | 2025 | Hymovis, Triluron |
| Bioventus LLC | $15.79 | 2024 | Durolane |
| Pacira Pharmaceuticals Incorporated | $12.81 | 2020 | |
| Heron Therapeutics, INC. | $4.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.